Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.
Robin von Rotz, Eva M Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter Nowak, Lutz Jäncke, Katrin H Preller, Franz X Vollenweider
EClinicalMedicine February 1, 2023 correction DOI: 10.1016/j.eclinm.2023.101841
Summary
This appears to be a correction notice for a previously published clinical trial. Without access to the specific details of the correction, I can only note that it addresses updates or amendments to an earlier study about psilocybin therapy for depression. For accurate information about this correction, please refer to the original document.
Abstract
[This corrects the article DOI: 10.1016/j.eclinm.2022.101809.].